The pharmacological management of behavioural disturbance in psychosis: A naturalistic study

Australasian Psychiatry

Volumn 15, Issue 5, 2007, Pages 380-384

  Daniel, Jeffrey ^a   Chamberlain, James ^b   Castle, David J ^c  

^a AUSTIN HEALTH   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Anti psychotics; Behavioural disturbance; Schizophrenia

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; DIAZEPAM; DROPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE;

ARTICLE; AUSTRALIA; BEHAVIOR DISORDER; BIPOLAR DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT SATISFACTION; PSYCHOSIS; SCHIZOPHRENIA;

ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; EMOTIONS; HUMANS; INPATIENTS; INTERVIEWS AS TOPIC; MENTAL DISORDERS; PSYCHOTIC DISORDERS; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME; VICTORIA;

EID: 34548641444     PISSN: 10398562     EISSN: 14401665     Source Type: Journal    
DOI: 10.1080/10398560701435754     Document Type: Article

References (8)

1. Castle, D., Daniel, D., Knott, J., Fielding, J., Goh, J. and Singh, B. (2005) Development of clinical guidelines for the pharmacological management of behavioural disturbance and aggression in people with psychosis. Australasian Psychiatry, 13, pp. 247-252.
2. Castle, D. and Alderton, D. (2006) Pharmacological and Psychosocial Treatments in Schizophrenia, pp. 89-102. Taylor and Francis, London
3. Allen, MH, Currier, GW and Hughes, DH (2001) The treatment of behavioural emergencies. Postgraduate Medicine, pp. 1-88.
4. McAllister-Williams, RH and Ferrier, IN. (2001) Rapid tranquillisation: time for a reappraisal of options for parenteral therapy. British Journal of Psychiatry, 179, pp. 485-489.
5. Wright, P., Birkett, M. and David, S. (2001) Double-blind, placebo-controlled comparison of intramuscular olanzapine and intramuscular haloperidol in the treatment of acute agitation in schizophrenia. American Journal of Psychiatry, 158, pp. 1149-1151.
6. Currier, GW and Simpson, GM. (2000) Risperidone liquid concentrate and oral lorazepam versus intramuscular haloperidol for treatment of psychotic agitation. Journal of Clinical Psychiatry, 62, pp. 153-157.
7. Kay, SR, Fiszbein, A. and Opler, LA. (1987) The Positive and Negative Symptom Scale (PANSS). Schizophrenia Bulletin, 13, pp. 261-276.
8. Williams, R. (2006) Generalized ordered logit/partial proportional odds models for ordinal dependent variables. The Stata Journal, 6, pp. 58-82.